Fatigue in HIV-infected men receiving investigational interleukin-2
Grady, C.; Anderson, R.; Chase, G.A.
Nursing Research 47(4): 227-234
1998
ISSN/ISBN: 0029-6562 PMID: 9683118 Document Number: 496353
Against a background of fatigue related to HIV infection and its multiple manifestations and treatments, therapy with IL-2 dramatically increases the experience of fatigue. Although this increase is transient and tends to return to baseline by 1 month, during that month the patient's life function and quality may be severely affected.
Document emailed within 1 workday
Related Documents
Radkowski, M.; Wang, L.F.; Vargas, H.; Wilkinson, J.; Rakela, J.; Laskus, T. 2001: Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors Transplantation 72(5): 833-838Wangnum, K.; Thanarojanawanich, T.; Chinwatanachai, K.; Jamprasert, L.; Maleehuan, O.; Janthakun, V. 2013: Impact of the multidisciplinary education program in self-care on fatigue in lung cancer patients receiving chemotherapy Journal of the Medical Association of Thailand 96(12): 1601-1608
Waldmann, T.A.; Goldman, C.K. 1989: The multichain interleukin-2 receptor: a target for immunotherapy of patients receiving allografts American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 14(5 Suppl 2: 45-53
Steciwko, A.; Mastalerz-Migas, A.; Rutkowski, Bław.; Simon, K. 2004: Problem of HIV-infected patients receiving dialysis Przeglad Lekarski 61(3): 185-191
Locker, G.J.; Kofler, J.; Stoiser, B.; Wilfing, A.; Wenzel, C.; Wögerbauer, M.; Steger, G.G.; Zielinski, C.C.; Mader, R.; Burgmann, H. 2000: Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2 European Cytokine Network 11(3): 391-396
Rainwater-Lovett, K.; Moss, W.J. 2011: Immunologic basis for revaccination of HIV-infected children receiving HAART Future Virology 6(1): 59-71
Butler, K.M.; Venzon, D.; Henry, N.; Husson, R.N.; Mueller, B.U.; Balis, F.M.; Jacobsen, F.; Lewis, L.L.; Pizzo, P.A. 1993: Pancreatitis in human immunodeficiency virus-infected children receiving dideoxyinosine Pediatrics 91(4): 747-751
Ragnarsson, A.; Thorson, A.; Dover, P.; Carter, J.; Ilako, F.; Indalo, D.; Ekstrom, A.Mia. 2011: Sexual risk-reduction strategies among HIV-infected men receiving ART in Kibera, Nairobi Aids Care 23(3): 315-321
Mwiru, R.S.; Spiegelman, D.; Duggan, C.; Seage, G.R.; Semu, H.; Chalamilla, G.; Kisenge, R.; Fawzi, W.W. 2014: Growth among HIV-infected children receiving antiretroviral therapy in Dar es Salaam, Tanzania Journal of Tropical Pediatrics 60(3): 179-188
Sevastianova, K.; Sutinen, J.; Westerbacka, J.; Ristola, M.; Yki-Järvinen, H. 2005: Arterial stiffness in HIV-infected patients receiving highly active antiretroviral therapy Antiviral Therapy 10(8): 925-935
Belaunzarán-Zamudio, P.F.; García-León, M.L.; Wong-Chew, R.M.ía.; Villasís-Keever, A.; Cuellar-Rodríguez, J.; Mosqueda-Gómez, J.L.; Muñoz-Trejo, T.; Escobedo, K.; Santos, J.é I.; Ruiz-Palacios, G.M.; Sierra-Madero, J.G. 2009: Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART Vaccine 27(50): 7059-7064
Alvarez, C.; Salazar, R.; Galindez, J.; Rangel, F.; Castaãeda, M.L.; Lopardo, G.; Cuhna, C.A.; Roldan, Y.; Sussman, O.; Gutierrez, G.; Cure-Bolt, N.; Seas, C.; Carcamo, C.; Castrillo, M. 2010: Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 14(3): 256-263
Benki-Nugent, S.; Eshelman, C.; Wamalwa, D.; Langat, A.; Tapia, K.; Okinyi, H.M.; John-Stewart, G. 2015: Correlates of age at attainment of developmental milestones in HIV-infected infants receiving early antiretroviral therapy Pediatric Infectious Disease Journal 34(1): 55-61
Machado, E.S.; Hofer, C.B.; Costa, T.T.; Nogueira, S.A.; Oliveira, R.H.; Abreu, T.F.; Evangelista, L.A.; Farias, I.F.A.; Mercadante, R.T.C.; Garcia, M.F.L.; Neves, R.C.; Costa, V.M.; Lambert, J.S. 2009: Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception Sexually Transmitted Infections 85(2): 82-87
Namutebi, A.M.N.; Kamya, M.R.K.; Byakika-Kibwika, P. 2013: Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda African Health Sciences 13(4): 977-985
Chuapai, Y.; Kiertiburanakul, S.; Malathum, K.; Sungkanuparph, S. 2007: Lipodystrophy and dyslipidemia in human immunodeficiency virus-infected Thai patients receiving antiretroviral therapy Journal of the Medical Association of Thailand 90(3): 452-458
Harrold, S.M.; Wang, G.; McMahon, D.K.; Riddler, S.A.; Mellors, J.W.; Becker, J.T.; Caldararo, R.; Reinhart, T.A.; Achim, C.L.; Wiley, C.A. 2002: Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy Aids Research and Human Retroviruses 18(6): 427-434
Abutidze, A.; Bolokadze, N.; Chkhartishvili, N.; Sharvadze, L.; Tsertsvadze, T. 2016: Incidence of Tuberculosis among Hiv/Hcv Co-Infected Patients Receiving Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Georgia Georgian Medical News 252: 10-15
Kityo, C.; Bousheri, S.; Akao, J.; Ssali, F.; Byaruhanga, R.; Ssewanyana, I.; Muloma, P.; Myalo, S.; Magala, R.; Lu, Y.; Mugyenyi, P.; Cao, H. 2011: Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase i safety study Vaccine 29(8): 1617-1623
Han, S.H.; Chin, B.S.; Choi, H.K.; Shin, S.Y.; Chae, Y.T.; Baek, J.-H.; Kim, C.O.; Choi, J.Y.; Song, Y.G.; Lee, H.C.; Kim, J.M. 2009: Prevalence of and clinical factors associated with lipoatrophy in HIV-infected Koreans receiving highly active antiretroviral therapy Tohoku Journal of Experimental Medicine 219(2): 145-153